Free Trial

Solaris Resources (SLS) Competitors

Solaris Resources logo
C$5.08 -0.04 (-0.78%)
As of 03/26/2025 04:00 PM Eastern

SLS vs. AUP, CARA, CRON, TEV, ABT, NOT, TLRY, PYR, NVO, and DNA

Should you be buying Solaris Resources stock or one of its competitors? The main competitors of Solaris Resources include Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), Tilray Brands (TLRY), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.

Solaris Resources vs.

Aurinia Pharmaceuticals (TSE:AUP) and Solaris Resources (TSE:SLS) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment, community ranking and profitability.

Solaris Resources has a consensus target price of C$13.50, suggesting a potential upside of 165.75%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts clearly believe Solaris Resources is more favorable than Aurinia Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Solaris Resources
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Solaris Resources has lower revenue, but higher earnings than Aurinia Pharmaceuticals. Solaris Resources is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A
Solaris ResourcesN/AN/A-C$46.49M-C$0.57-8.85

In the previous week, Aurinia Pharmaceuticals had 1 more articles in the media than Solaris Resources. MarketBeat recorded 1 mentions for Aurinia Pharmaceuticals and 0 mentions for Solaris Resources. Aurinia Pharmaceuticals' average media sentiment score of 1.34 beat Solaris Resources' score of 0.00 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Aurinia Pharmaceuticals Positive
Solaris Resources Neutral

25.1% of Solaris Resources shares are owned by institutional investors. 40.6% of Solaris Resources shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aurinia Pharmaceuticals received 233 more outperform votes than Solaris Resources when rated by MarketBeat users. Likewise, 72.22% of users gave Aurinia Pharmaceuticals an outperform vote while only 48.28% of users gave Solaris Resources an outperform vote.

CompanyUnderperformOutperform
Aurinia PharmaceuticalsOutperform Votes
247
72.22%
Underperform Votes
95
27.78%
Solaris ResourcesOutperform Votes
14
48.28%
Underperform Votes
15
51.72%

Aurinia Pharmaceuticals' return on equity of 0.00% beat Solaris Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurinia PharmaceuticalsN/A N/A N/A
Solaris Resources N/A -438.08%-51.67%

Summary

Solaris Resources beats Aurinia Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

Remove Ads
Get Solaris Resources News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLS vs. The Competition

MetricSolaris ResourcesOther Precious Metals & Mining IndustryMaterials SectorTSE Exchange
Market CapC$582.75MC$253.42MC$3.13BC$5.71B
Dividend YieldN/A6.06%5.14%6.83%
P/E Ratio-8.8511.0383.1830.19
Price / SalesN/A12,253,509.2125,591,212,775,397,300.00495.15
Price / Cash64.5313.1024.3283.07
Price / Book52.489.615.123.65
Net Income-C$46.49M-C$2.74MC$153.88MC$299.79M
7 Day Performance-0.97%-0.71%0.17%-0.12%
1 Month Performance4.53%7.20%5.51%0.28%
1 Year Performance14.41%40.26%30.03%29.57%

Solaris Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLS
Solaris Resources
N/AC$5.08
-0.8%
C$13.50
+165.7%
+14.4%C$582.75MN/A-8.8510
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading Volume
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/A0.0080
CRON
Cronos Group
1.2261 of 5 stars
C$2.67
-0.7%
C$3.54
+32.6%
-29.0%C$705.05MC$76.86M-14.86450
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
TLRY
Tilray Brands
N/AC$0.95
+3.3%
N/A-70.0%C$612.15MC$610.34M-2.302,650Gap Down
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
Remove Ads

Related Companies and Tools


This page (TSE:SLS) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners